Generics Eat Into Pfizer's Sales

Pfizer's quarterly revenue fell as generic competition over blockbuster drugs like Viagra cut into sales. And the world's largest drug maker cut its revenue outlook for the full year because it foresees further generic competition eating into another big seller, its $3 billion anti-arthritis drug, Celebrex. It had lost a court ruling that now makes it possible for generic makers like Teva and Mylan to launch their versions in December.

Topics:  viagra   celebrex   teva   mylan   december   eat   pfizer's   sales   generic   revenue   cut   competition   drug   
BING NEWS:
  • BridgeBio Pharma: Assessing Acoramidis' Market Opportunity, Further Upside Potential Evident
    BridgeBio's acoramidis seems likely to secure approval in November, in the large market of ATTR-cardiomyopathy. Read more to see our analysis on BBIO stock.
    03/21/2024 - 11:49 pm | View Link
  • Bristol-Myers Squibb Is Not A Buy For Me
    Bristol-Myers Squibb may be on the value menu for a while as the acquisition strategy may take time to pay off. Read more to see our analysis on BMY stock.
    03/18/2024 - 11:46 pm | View Link
  • FTSE 100 Live 18 March: Alphabet and Nvidia surge in US, London shares flat as BT slides
    65-year-old Soho-based Ronnie Scott’s, famed for hosting music legends such as Miles Davis, Nina Simone and Jimi Hendrix, showed signs of a strong recovery after the pandemic, with sales of £14 ...
    03/18/2024 - 6:11 am | View Link
  • More

 

Welcome to Wopular!

Welcome to Wopular

Wopular is an online newspaper rack, giving you a summary view of the top headlines from the top news sites.

Senh Duong (Founder)
Wopular, MWB, RottenTomatoes

Subscribe to Wopular's RSS Fan Wopular on Facebook Follow Wopular on Twitter Follow Wopular on Google Plus

MoviesWithButter : Our Sister Site

More Business News